CAELUS PHARMACEUTICALS
DEAD

Serial Number

79399417

Owner

Caelus Pharmaceuticals B.V.

Filing Date

Jun 5, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CAELUS PHARMACEUTICALS Trademark

Serial Number: 79399417

CAELUS PHARMACEUTICALS is a trademark filed by Caelus Pharmaceuticals B.V. on June 5, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Caelus Pharmaceuticals B.V. (9 trademarks)

Rondweg 50

Entity Type: 98

Trademark Details

Filing Date

June 5, 2024

Registration Date

Not Registered

Goods & Services

Scientific and technological services, and also assorted development and design; medical and pharmacological research services; development of pharmaceutical preparations, including vaccines and medicines; development of pharmaceutical products, carrying out evaluation of pharmaceutical products, conducting testing of pharmaceutical products, research in the field of pharmaceutical products, including medicines and vaccines; research in the field of pharmaceutical products, medicines and vaccines; laboratory research services related to pharmaceutical products, including medicines and vaccines; research and development in the field of new pharmaceutical products, including medicines and vaccines; research and development in the field of new products, food supplements and supplements, food for medical use; research and development in the field of new food supplements for human consumption; scientific research in the field of pharmacy; scientific research in the field of food and food supplements for the human body.

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 18, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 3, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 3, 2025 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Sep 13, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sep 13, 2025 ABN2
REFUSAL PROCESSED BY IB
Apr 4, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 20, 2025 RFCS
REFUSAL PROCESSED BY MPU
Feb 20, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 9, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jan 8, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 16, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 12, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 12, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 8, 2024 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jul 5, 2024 SDRC